Filing Details

Accession Number:
0001209191-13-031640
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-06-11 17:15:47
Reporting Period:
2013-06-10
Filing Date:
2013-06-11
Accepted Time:
2013-06-11 17:15:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1333248 Cadence Pharmaceuticals Inc CADX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1557146 Malcolm Lloyd-Smith 12481 High Bluff Dr.
Ste. 200
San Diego CA 92130
Svp, Reg Affairs, Qual & Clin No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2013-06-10 4,000 $7.44 2,332 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 9, 2013.